The signaling pathway of 3-phosphatidyloinositol and AKT protein kinase plays an important role in the development of MDR in various cancers, e.g., breast cancer, lung cancer, leukemia, ovarian cancer and melanoma [19,20,21]. This evidence concerns the gene AKT1 and ovarian carcinoma.